Implications of SH3 domain structure and dynamics for protein regulation and drug design

Cell Biochemistry and Biophysics

Volumn 35, Issue 2, 2001, Pages 127-140

  Gmeiner, William H ^a   Horita, David A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Drug Design; NMR; Protein Dynamics; SH3 domain; Signal Transduction

Indexed keywords

LIGAND; PROTEIN;

ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; HUMAN; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

ANIMALS; DRUG DESIGN; HUMANS; LIGANDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 0035749903     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:35:2:127     Document Type: Article

References (87)

1. Pawson, T. and Scott, J. D. (1997) Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080.
2. Mihich, E. and Harlow, E. (2000) Twelfth annual Pezcoller Symposium: signaling cross-talks in cancer cells. Cancer Res. 60, 7177-7183.
3. Kuriyan, J. and Cowburn, D. (1997) Modular peptide recognition domains in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26, 259-288.
4. Horita, D. A., Baldiserri, D. M., Zhang, W., Altieri, A. S., Smithgall, T. E., Gmeiner, W. H., and Byrd, R. A. (1998) Solution structure of the human Hck SH3 domain and identification of its ligand binding site. J. Mol. Biol. 278, 253-265.
5. Eck, M. J., Atwell, S. K., Shoelson, S. E., and Harrison, S. C. (1994) Crystal structure of the regulatory domains of the Src-family tyrosine kinase lck. Nature 368, 764-769.
6. Engen, J. R., Smithgall, T. E., Gmeiner, W. H., and Smith, D. L. (1997) Identification of a slow, natural, cooperative unfolding in the hematopoietic cellular kinase SH3 domain by amide hydrogen exchange and mass spectrometry. Biochemistry 36, 14,384-14,391.
7. Engen, J. R., Smithgall, T. E., Gmeiner, W. H., and Smith, D. L. (1999) Comparison of SH3 and SH2 domain dynamics when expressed alone or in an SH(3+2) construct: the role of protein dynamics in functional regulation. J. Mol. Biol. 287, 645-656.
8. Brown, M. T. and Cooper, J. A. (1996) Regulation, substrates, and functions of Src. Biochim. Biophys. Acta 1287, 121-149.
9. Sudol, M. (1998) From Src Homology domains to other signaling modules: proposal of the 'protein recognition code.' Oncogene 17, 1469-1474.
10. Ladbury, J. E. and Arold, S. (2000) Searching for specificity in SH domains. Chem. Biol. 7, R3-R8.
11. Mayer, B. J. and Gupta, R. (1998) Functions of SH2 and SH3 domains. Curr. Top. Microbiol. Immunol. 228, 1-22.
12. Ottinger, E. A., Botfield, M. C., and Shoelson, S. E. (1998) Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol. Chem. 273, 729-735.
13. Vihinen, M. and Smith, C. I. E. (1998) Interactions between SH2 and SH3 domains. Biochem. Biophys. Res. Commun. 242, 351-356.
14. Yu, H., Rosen, M. K., Shin, T. B., Seidel-Duggan, C., Brugge, J. S., and Schreiber, S. L. (1992) Solution structure of the SH3 domain of Src and identification of its ligand binding site. Science 258, 1665-1668.
15. Musacchio, A., Noble, M., Paupit, R., Wierenga, R., and Saraste, M. (1992) Crystal structure of a Src-homology 3 (SH3) domain. Nature 359, 851-855.
16. Arold, S., O'Brien, R., Franken, P., Strub, M-P., Hoh, F., Dumas, C., and Ladbury, J. E. (1998) RT loop flexibility enhances the specificity of Src family SH3 domains for HIV-1 Nef. Biochemistry 37, 14,683-14,691.
17. Politou, A. S., Millevoi, S., Gautel, M., Kolmerer, B., and Pastore, A. (1998) SH3 in muscles: Solution structure of the SH3 domain from nebulin. J. Mol. Biol. 276, 189-202.
18. Pauli, J., van Rossum, B., Forster, H., de Groot, H. J. M., and Oschkinat, H. (2000) Sample optimization and identification of signal patterns of amino acid side chains in 2D RFDR spectra of the α-spectrin SH3 domain. J. Magn. Reson. 143, 411-416.
19. Cohen, G. B., Ren, R., and Baltimore, D. (1995) Modular binding domains in signal transduction proteins. Cell 80, 237-248.
20. Saksela, K., Cheng, G., and Baltimore, D. (1995) Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for me enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J. 14, 484-491.
21. Feng, S., Kasahara, C., Rickles, R. J., and Schreiber, S. L. (1995) Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. USA 92, 12,408-12,415.
22. Saksela, K. (1997) Hiv-1 Nef and host cell protein kinases. Frontiers Biosci. 2, d606-618.
23. Aghazadeh, B. and Rosen, M. K. (1999) Ligand recognition by SH3 and WW domains: the role of N-alkylation in PPII helices. Chem. Biol. 6, R241-R246.
24. Mongiovi, A. M., Romano, P. R., Panni, S., Mendoza, M., Wong, W. T., Musacchio, A., et al. (1999) A novel peptide-SH3 interaction. EMBO J. 18, 5300-5309.
25. Kishan, K. V. R., Scita, G., Wong, W. T., Di Fiore, P. P., and Newcomer, M. E. (1997) The SH3 domain of EPS8 exists as a novel intertwined dimer. Nature Struct. Biol. 4, 739-743.
26. Falzone, C. J., Kao, Y. H., Zhao, J., Bryant, D. A., and Lecomte, J. T. (1994) Three-dimensional solution structure of PsaE from the cyanobacterium Synechococus sp. strain PCC 7002, a photosystem I protein that shows structural homology with SH3 domains. Biochemistry 33, 6052-6062.
27. Altschul, S. F., Madden, T. L., Schaffer, A. A., Zhang, J., Zhang, Z., Miller, W., and Lipman, D. J. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402.
28. Whisstock, J. C. and Lesk, A. M. (1999) SH3 domains in prokaryotes. Trends Biochem Sci. 24, 32-33.
29. Hess, J., Dreher, A., Genschev, I., Goebel, W., Ladel, C., Miko, D., and Kaufmann, S. H. (1996) Protein p60 participates in intestinal host invasion by Listeria monocytogenes. Zentralblatt fur Bakteriologie 284, 263-272.
30. Hess, J., Gentschev, I., Szalay, G., Ladel, C., Bubert, A., Goebel, W., and Kaufmann, S. H. (1995) Listeria monocytogenes p60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium. Infect. Immun. 63, 2047-2053.
31. Tang, P., Rosenshine, I., and Finlay, B. B. (1994) Listeria monocytogenes, an invasive bacterium, stimulates MAP kinase upon attachment to epitheliel cells. Mol. Biol. Cell 5, 455-464.
32. Bilwes, A. M., Alex, L. A., Crane, B. R., and Simon, M. I. (1999) Structure of CheA, a signal-transducing histidine kinase. Cell 96, 131-141.
33. Pohl, E., Holmes, R. K., and Hol, W. G. J. (1999) Crystal structure of a cobalt-activated diphtheria toxin repressor-DNA complex reveals a metal-binding SH3-like domain. J. Mol. Biol. 292, 653-667.
34. Kestler, H. W. I., Ringler, D. J., Mori, K., Panicalli, D. L., Sehgal, P. K., Daniel, M. D., and Desrosiers, R. C. (1991) Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651-662.
35. Kirchoff, F., Greenhough, T. C., Brettler, D. B., Sullivan, J. L., and Desrosiers, R. C. (1995) Absence of intact nef sequences in a long-term survivor with non-progressive HIV-1 infection. N. Engl. J. Med. 332, 228-232.
36. Saksela, N. K., Ge, Y. C., Wang, B., Xiang, S.-H., Ziegler, J., Palasanthiran, P., et al. (1997) RNA and DNA sequence analysis of the nef gene of HIV type 1 strains from the first HIV type 1-infected long-term nonprogressing motherchild pair. AIDS Res. Hum. Retr. 13, 729-732.
37. Craig, H. M., Pandori, M. W., Riggs, N. L., Richman, D. D., and Guatelli, J. C. (1999) Analysis of the SH3-binding region of HIV-1 Nef: partial functional defects introduced by mutations in the polyproline helix and the hydrophobic pocket. Virology 262, 55-63.
38. Sawai, E. T., Bauer, A., Struble, H., Peterlin, B. M., Levy, J. A., and Cheng-Mayer, C. (1994) Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. USA 91, 1539-1543.
39. Manninen, A., Hiipakka, M., Vihinen, M., Lu, W., Mayer, B. J., and Saksela, K. (1998) SH3-domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 250, 273-282.
40. Greenberg, M. E., Iafrate, A. J., and Skowronski, J. (1998) The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes. EMBO J. 17, 2777-89.
41. Balter, M. (1997) HIV's other immune-system targets: macrophages. Science 274, 1464-1465.
42. Lee, C. H., Leung, B., Lemmon, M. A., Zheng, J., Cowburn, D., Kuriyan, J., and Saksela, K. (1995) A single amino acid in the SH3 domain of Hck determines its high affinity and specificity in binding to HIV1 Nef protein. EMBO J. 14, 5006-5015.
43. Lee, C. H., Saksela, K., Mirza, U. A., Chait, B. T., and Kuriyan, J. (1996) Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85, 931-942.
44. Arold, S., Franken, P., Strub, M-P., Hoh, F., Benichou, S., Benarous, R., and Dumas, C. (1997) The crystal structure of HIV-1 Nef protein bound to the Fyn Kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5, 1361-1372.
45. Briggs, S. D., Sharkey M., Stevenson, M., and Smithgall, T. E. (1997) SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J. Biol. Chem. 272, 17,899-17,902.
46. Greenway, A., Azad, A., Mills, J., and McPhee, D. (1996) Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J. Virol. 70, 6701-6708.
47. Gonfloni, S., Weijland, A., Kretzschmar, J., and Superti-Furga, G. (2000) Crosstalk between the catalytic and regulatory domains allows bidi-rectional regulation of Src. Nat. Struct. Biol. 7, 281-286.
48. Sicheri, F., Moarefi, I., and Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
49. Xu, W., Harrison, S. C., and Eck, M. J. (1997) Three dimensional structure of the tyrosine kinase c-Src Nature 385, 595-602.
50. Murphy, S. M., Bergman, M., and Morgan, D. O. (1993) Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisae. Mol. Cell. Biol. 13, 5290-5300.
51. Songyang, Z., Shoelson, S. E., Chaudhuri, M., Gish, G., Pawson, T., Haser, W. G., et al. (1993) SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778.
52. 416. Effect of introducing a high affinity intramolecular SH2 ligand. J. Biol. Chem. 275, 2721-2726.
53. Miyazaki, K., Senga, T., Matsuda, S., Tanaka, M., Machida, K., Takenouchi, Y., et al. (1999) Critical amino acid substitutions in the Src SH3 domain that convert c-Src to be an oncogene. Biochem. Biophys. Res. Commun. 263, 759-764.
54. Farrow, N. A., Zhang, O., Forman-Kay, J. D., and Kay, L. E. (1995) Comparison of the backbone dynamics of a folded and an unfolded SH3 domain existing in equilibrium in aqueous buffer. Biochemistry 34, 868-878.
55. Farrow, N. A., Zhang, O., Forman-Kay, J. D., and Kay, L. E. (1997) Characterization of the backbone dynamics and denatured states of an SH3 domain. Biochemistry 36, 2390-2402.
56. Wittekind, M., Mapelli, C., Lee, V., Goldfarb, V., Friedrichs, M. S., Meyers, C. A., and Mueller, L. (1997) Solution structure of the Grb2 N-terminal SH3 domain complexed with a ten-residue peptide derived from SOS: Direct refinement against NOEs, J-couplings and 1H and 13C chemical shifts. J. Mol. Biol. 267, 933-952.
57. Mok, Y-K, Kay, C. M., Kay, L. E., and Forman-Kay, J. (1999) NOE data demonstrating a compact unfolded state for an SH3 domain under non-denaturing conditions. J. Mol. Biol. 289, 619-638.
58. Kortemme, T., Kelly, M. J., Kay, L. E., Forman-Kay, J., and Serrano, L. (2000) Similarities between the spectrin SH3 domain denatured state and its folding transition state. J. Mol. Biol. 297, 1217-1229.
59. Martinez, J. C., Viguera, A. R., Berisio, R., Wilmanns, M., Mateo, P. L., Filimonov, V. V., and Serrano, L. (1999) Thermodynamic analysis of α-spectrin SH3 and two of its circular permutants with different loop lengths: discerning the reasons for rapid folding in proteins. Biochemistry 38, 549-559.
60. Tsai, J., Levitt, M., and Baker, D. (1999) Hierarchy of structure loss in the MD simulations of Src SH3 domain unfolding. J. Mol. Biol. 291, 215-225.
61. Horita, D. A., Zhang, W., Smithgall, T. E., Gmeiner, W. H., and Byrd, R. A. (2000) Dynamics of the Hck-SH3 domain: Comparison of experiment with multiple molecular dynamics simulations. Protein Sci. 9, 95-103.
62. Hansson, H., Mattsson, P. T., Allard, P., Haapaniemi, P., Vihinen, M., Smith, C. I. E., and Hard, T. (1998) Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37, 2912-2924.
63. Parrini, M. C. and Mayer, B. J. (1999) Engineering temperature-sensitive SH3 domains. Chem. Biol. 6, 679-687.
64. Maxwell, K. L. and Davidson, A. R. (1998) Mutagenesis of a buried polar interaction in an SH3 domain: sequence conversation provides the best prediction of stability effects. Biochemistry 37, 16,172-16,182.
65. Engen, J. R., Gmeiner, W. H., Smithgall, T. E., and Smith, D. L. (1999) Hydrogen exchange shows peptide binding stabilizes motions in Hck Sh2. Biochemistry 38, 8926-8935.
66. 15N-labeled proteins using a 3D 13C′-edited NOESY-H(N)CO experiment. J. Magn. Reson. B 111, 305-309.
67. Zhang, W. and Gmeiner, W. H. (1996) Improved 3D gd-HCACO and gd-(H)CACO-TOCSY experiments for isotopically enriched proteins dissolved in H2O. J. Biomol. NMR 7, 247-250.
68. 2O. J. Biomol. NMR 8, 357-359.
69. Zhang, W., Smithgall, T. E., and Gmeiner, W. H. (1997) Sequential assignment and secondary structure determination for the Src homology 2 domain of hematopoietic cellular kinase. FEBS Lett. 406, 131-135.
70. Zhang, W., Smithgall, T. E., and Gmeiner, W. H. (1997) The solution structure of the Src-homology 2 domain from the hematopoietic cellular kinase. J. Biomol. NMR 10, 263-272.
71. Zhang, W., Smithgall, T. E., and Gmeiner, W. H. (1998) Self-association and backbone dynamics of the Hck SH2 domain in the free and phosphopeptide-complexed form. Biochemistry 37, 7119-7126.
72. 15N NMR relaxation. Biochemistry 33, 5984-6003.
73. Kay, L. E., Muhandiram, D. R., Wolf, G., Shoelson, S. E., and Forman-Kay, J. D. (1998) Correlation between binding and dynamics at SH2 domain interfaces. Nat. Struct. Biol. 5, 156-163.
74. Cheng, J., Lepre, C. A., Chambers, S. P., Fulghum, J. R., Thomson, J. A., and Moore, J. M. (1993) 15N NMR relaxation studies of the FK506 binding protein: Backbone dynamics of the uncomplexed receptor. Biochemistry 32, 9000-9010.
75. Fushman, D., Weiseman, R., Thuring, H., and Ruterjans, H. (1994) Backbone dynamics of ribonuclease T1 and its complex with 2′GMP studied by two-dimensional heteronuclear NMR spectroscopy. J. Biomol. NMR 4, 61-78.
76. Fushman, D., Cahill, S., and Cowburn, D. (1997) The main chain dynamics of the dynamin plekstrin homology (PH) domain in solution: analysis of 15N relaxation with monomer/dimer equilibration. J. Mol. Biol. 266, 173-194.
77. Nicholson, L. K., Kay, L. E., Baldisseri, D. M., Arango, J., Young, P. E., Bax, A., and Torchia, D. A. (1992) Dynamics of methyl groups in proteins as studied by proton-detected 13C NMR spectroscopy. Application to the leucine residues of staphylococcal nuclease. Biochemistry 31, 5253-5263.
78. Grucza, R. A., Bradshaw, J. M., Futterer, K., and Waksman, G. (1999) SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships. Med. Res. Rev. 19, 273-293.
79. Levitzki, A. (1996) Targeting signal transduction for disease therapy. Curr. Opin. Cell Biol. 8, 239-244.
80. Dalgarno, D. C., Botfield, M. C., and Rickless, R. J. (1998) SH3 domains and drug design: Ligands, structure, and biological function. Biopolymers 43, 383-400.
81. Feng, S., Kapoor, T. M., Shirai, F., Combs, A. P., and Screiber, S. L. (1996) Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesis. Chem. Biol. 3, 661-670.
82. Schumacher, T. N. M., Mayr, L. M., Minor, D. L. Jr., Milhollen, M. A., Burgess, M. W., and Kim, P. S. (1996) Identification of D-peptide ligands through mirror-image phage display. Science 271, 1854-1855.
83. Witter, D. J., Famiglietti, S. J., Cambier, J. C., and Castelhano, A. L. (1998) Design and synthesis of SH3 domain binding ligands: modifications of the consensus sequence XPpXP. Bioorg. Med. Chem. 8, 3137-3142.
84. Kardinal, C., Posern, G., Zheng, J., Knudsen, B. S., Amgen Peptide Technology Group, Moarefi, I., and Feller, S. M. (1999) Rational development of cell-penetrating high affinity SH3 domain binding peptides that selectively disrupt the signal transduction of Crk family adapters. Ann. NY Acad. Sci. 886, 289-292.
85. Posern, G., Zheng, J., Knudsen, B. S., Kardinal, C., Muler, K. B., Voss, J., et al. (1998) Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G. Oncogene 16, 1903-1912.
86. Xu, Q., Zheng, J., Xu, R., Barany, G., and Cowburn, D. (1999) Flexibility of interdomain contacts revealed by topological isomers of bivalent consolidated ligands to the dual Src homology domain SH(32) of Abelson. Biochemistry 38, 3491-3497.
87. Sawyer, T. K. (1998) Src homology-2 domains: structure, mechanisms, and drug discovery. Biopolymers 47, 243-261.